當前位置：首頁 JCRQ2 期刊介紹(非官網)

Clinica Chimica ActaSCIE

國際簡稱：CLIN CHIM ACTA 參考譯名：Acta 化學診所

中科院分區
3區
CiteScore分區
Q1
JCR分區
Q2

基本信息：: ISSN：0009-8981; E-ISSN：1873-3492; 是否OA：未開放; 是否預警：否; TOP期刊：否

出版信息：: 出版地區：NETHERLANDS; 出版商：Elsevier; 出版語言：English; 出版周期：Monthly; 出版年份：1956; 研究方向：醫學-醫學實驗技術

評價信息：: 影響因子：3.2; H-index：127; CiteScore指數：10.1; SJR指數：1.016; SNIP指數：1.086

發文數據：: Gold OA文章占比：16.95%; 研究類文章占比：91.13%; 年發文量：327; 自引率：0.02; 開源占比：0.0813; 出版撤稿占比：0; 出版國人文章占比：0.19; OA被引用占比：0.0316...

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數據中科院SCI分區 JCR分區發文數據常見問題

英文簡介Clinica Chimica Acta期刊介紹

The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)

Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.

The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal's scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.

期刊簡介Clinica Chimica Acta期刊介紹

《Clinica Chimica Acta》自1956出版以來，是一本醫學優秀雜志。致力于發表原創科學研究結果，并為醫學各個領域的原創研究提供一個展示平臺，以促進醫學領域的的進步。該刊鼓勵先進的、清晰的闡述，從廣泛的視角提供當前感興趣的研究主題的新見解，或審查多年來某個重要領域的所有重要發展。該期刊特色在于及時報道醫學領域的最新進展和新發現新突破等。該刊近一年未被列入預警期刊名單，目前已被權威數據庫SCIE收錄，得到了廣泛的認可。

該期刊投稿重要關注點：

預計審稿時間：約3.0個月約5.2周
醫學
MEDICAL LABORATORY TECHNOLOGY
SCIE
中科院3區
非預警

Cite Score數據（2024年最新版）Clinica Chimica Acta Cite Score數據

CiteScore：10.1
SJR：1.016
SNIP：1.086

學科類別	分區	排名	百分位
大類：Medicine 小類：Biochemistry (medical)	Q1	10 / 72	86%
大類：Medicine 小類：Biochemistry	Q1	60 / 438	86%
大類：Medicine 小類：Clinical Biochemistry	Q1	18 / 117	85%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻計量指標。反映出一家期刊近期發表論文的年篇均引用次數。CiteScore以Scopus數據庫中收集的引文為基礎，針對的是前四年發表的論文的引文。CiteScore的意義在于，它可以為學術界提供一種新的、更全面、更客觀地評價期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標來評價。

歷年Cite Score趨勢圖

中科院SCI分區Clinica Chimica Acta 中科院分區

中科院 2023年12月升級版 綜述期刊：否 Top期刊：否

大類學科	分區	小類學科	分區
醫學	3區	MEDICAL LABORATORY TECHNOLOGY 醫學實驗技術	3區

中科院分區表 是以客觀數據為基礎，運用科學計量學方法對國際、國內學術期刊依據影響力進行等級劃分的期刊評價標準。它為我國科研、教育機構的管理人員、科研工作者提供了一份評價國際學術期刊影響力的參考數據，得到了全國各地高校、科研機構的廣泛認可。

中科院分區表 將所有期刊按照一定指標劃分為1區、2區、3區、4區四個層次，類似于“優、良、及格”等。最開始，這個分區只是為了方便圖書管理及圖書情報領域的研究和期刊評估。之后中科院分區逐步發展成為了一種評價學術期刊質量的重要工具。

歷年中科院分區趨勢圖

JCR分區Clinica Chimica Acta JCR分區

2023-2024 年最新版

按JIF指標學科分區	收錄子集	分區	排名	百分位
學科：MEDICAL LABORATORY TECHNOLOGY	SCIE	Q2	9 / 30	71.7%

按JCI指標學科分區	收錄子集	分區	排名	百分位
學科：MEDICAL LABORATORY TECHNOLOGY	SCIE	Q1	7 / 30	78.33%

JCR分區的優勢在于它可以幫助讀者對學術文獻質量進行評估。不同學科的文章引用量可能存在較大的差異，此時單獨依靠影響因子(IF)評價期刊的質量可能是存在一定問題的。因此，JCR將期刊按照學科門類和影響因子分為不同的分區，這樣讀者可以根據自己的研究領域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發文數據

2023-2024 年國家/地區發文量統計

國家/地區數量
CHINA MAINLAND660
Spain570
USA256
Italy215
GERMANY (FED REP GER)116
Belgium112
Japan104
France101
England87
India78

本刊中國學者近年發表論文

1、A rapid multiplex assay of human malaria parasites by digital PCR
Author: Dong, Liu; Li, Weijia; Xu, Qianqian; Gu, Jianfei; Kang, Zhihua; Chen, Jian; Xu, Xiao; Zhang, Xinju; Zhang, Xiuming; Jiang, Haoqin; Guan, Ming

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 539, Issue , pp. 70-78. DOI: 10.1016/j.cca.2022.12.001
2、The value of lipid metabolites 9,10-DOA and 11,12-EET in prenatal diagnosis of fetal heart defects
Author: Fang, Yiwei; Zhang, Zheng; Zhao, Yun; Sun, Guoqiang; Peng, Meilin; Liu, Chunyan; Yi, Guilin; Zhao, Kai; Yang, Hui

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 544, Issue , pp. -. DOI: 10.1016/j.cca.2023.117330
3、Biomarkers for chemotherapy and drug resistance in the mismatch repair pathway
Author: Dong, Liu; Jiang, Haoqin; Kang, Zhihua; Guan, Ming

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 544, Issue , pp. -. DOI: 10.1016/j.cca.2023.117338
4、Long noncoding RNA HAND2-AS1: A crucial regulator of malignancy
Author: Huang, Ziyue; Wang, Zhensheng; Xia, Haoming; Ge, Ziqiang; Yu, Liang; Li, Jiehan; Bao, Haolin; Liang, Zixin; Cui, Yunfu; Xu, Yi

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 539, Issue , pp. 162-169. DOI: 10.1016/j.cca.2022.12.010
5、Diagnostic potential of site-specific serotransferrin N-glycosylation in discriminating different liver diseases
Author: Zhang, Jiyun; Lai, Zhizhen; Ding, Rui; Zhou, Jinyu; Yuan, Zhonghao; Li, Dan; Qin, Xuzhen; Zhou, Jiang; li, Zhili

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 539, Issue , pp. 175-183. DOI: 10.1016/j.cca.2022.12.015
6、Fibrinogen beta chain may be a potential predict biomarker for pre-eclampsia: A preliminary study
Author: Shi, Junzhu; Zeng, Shanshui; Zhang, Yonggang; Zuo, Zhihua; Tan, Xiaoyu

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 539, Issue , pp. 206-214. DOI: 10.1016/j.cca.2022.12.012
7、Evaluating the value of anti-SARS-CoV-2 antibody detection and neutralizing responses with euvirus: A population of 10776 close contacts in the epidemic of Fujian
Author: Zeng, Yongbin; Lin, Caorui; Liu, Can; Huang, Chun; Chen, Falin; Cao, Yingping; Wu, Siying; Wei, Donghong; Lin, Zhong; Zhang, Yali; Zhang, Ling; Teng, Jing; Li, Zishun; Hong, Guolin; Yang, Tianci; Ye, Huiming; Tu, Haijian; Xiao, Yupeng; Huang, Lishan; Zhang, Jiawei; Chen, Tianbin; Li, Jinming; Ji, Fusui; Ou, Qishui

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 539, Issue , pp. 237-243. DOI: 10.1016/j.cca.2022.12.017
8、Intrafollicular fluid metabolic abnormalities in relation to ovarian hyperstimulation syndrome: Follicular fluid metabolomics via gas chromatography-mass spectrometry
Author: Sun, Yixuan; Hao, Lijuan; Han, Wei; Luo, Jing; Zheng, Jing; Yuan, Dong; Ye, Hong; Li, Qinke; Huang, Guoning; Han, Tingli; Yang, Zhu

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 538, Issue , pp. 189-202. DOI: 10.1016/j.cca.2022.11.033